CAS 150450-53-6

4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-

Description:

4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro- is a chemical compound characterized by its quinazolinamine core, which is a bicyclic structure containing both a benzene and a pyrimidine ring. The presence of a chloro substituent at the 6-position of the quinazolinamine enhances its reactivity and potential biological activity. The N-(1,3-benzodioxol-5-ylmethyl) group indicates that the compound has a benzodioxole moiety, which is known for its role in various pharmacological activities. This compound may exhibit properties such as antimicrobial, anti-inflammatory, or anticancer effects, making it of interest in medicinal chemistry. Its molecular structure suggests potential interactions with biological targets, and its unique functional groups may influence its solubility, stability, and overall bioavailability. As with many synthetic organic compounds, understanding its characteristics, including melting point, solubility, and spectral properties, is crucial for its application in research and development. Safety data and handling precautions should also be considered due to the presence of chlorine and other reactive groups.

Formula: C₁₆H₁₂ClN₃O₂

4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-

CAS: 150450-53-6

Formula: C₁₆H₁₂ClN₃O₂

Purity: 99%

Color and Shape: Solid

Molecular weight: 313.7384

Ref: IN-DA001MMS

MBCQ

CAS: 150450-53-6

MBCQ

Formula: C₁₆H₁₂ClN₃O₂

Purity: ≥98%

Molecular weight: 313.74

Ref: 54-BUP15567

MBCQ

CAS: 150450-53-6

MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.

Formula: C₁₆H₁₂ClN₃O₂

Purity: 99.45%

Color and Shape: Solid

Molecular weight: 313.74

Ref: TM-T21965